Fig. 1.
Mean change from baseline total UPDRS score in a parallel design fixed dose trial comparing placebo (1) and drug that has purely symptomatic (2), purely disease-modifying (3), or combined symptomatic plus disease-modifying treatments
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.